Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleus
tau 蛋白和衰老引起的神经功能障碍的机制:聚焦于细胞核
基本信息
- 批准号:10532781
- 负责人:
- 金额:$ 58.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-15 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAdultAffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease patientAnimalsArchitectureAutopsyBioinformaticsBiological ProcessBrainCell DeathCell NucleusCytoplasmDepositionDevelopmentDiseaseDrosophila genusDrosophila melanogasterEtiologyF-ActinFrequenciesFunctional disorderFutureGenesGeneticGenetic TranscriptionGenomeGoalsHumanInduced pluripotent stem cell derived neuronsIntermediate FilamentsInterruptionInvestigationLamin Type ALaminsLipid BilayersMalignant NeoplasmsMechanical StressMediatingMediatorModelingMutationNeurodegenerative DisordersNeurologic DysfunctionsNeuronal DysfunctionNeuronsNuclearNuclear EnvelopeNuclear PoreNucleoplasmPathologicPathway interactionsPeptidesPhenotypePhysiologicalPoly(A)+ RNAPolyadenylationPremature aging syndromeProductionProgeriaProsencephalonProteinsQuality ControlRNARNA DecayReportingResearchReticulumRisk FactorsRoleSamplingStructureSurfaceSyndromeSystemTauopathiesTestingTherapeutic InterventionTranscriptTransgenic OrganismsTubular formationVirus DiseasesVisualizationage relatedagedaging brainbrain tissuecell typeexperimental studyinduced pluripotent stem cellmodel organismneuron lossneurotoxicitynew therapeutic targetnovelnovel therapeutic interventionoptogeneticspharmacologicprogramsresponsetau Proteinstau mutation
项目摘要
PROJECT SUMMARY
The nuclear envelope is a lipid bilayer that encases the genome and provides a physical boundary between
the cytoplasm and the nucleoplasm. While the nucleus is typically depicted as a sphere encircled by a smooth
surface of nuclear envelope, the smooth exterior can be interrupted by tubular invaginations of the nuclear
envelope into the deep nuclear interior. Such structures are termed the “nucleoplasmic reticulum.” Increased
frequency of nuclear envelope invagination occurs in disease states including various cancers, viral infections,
and laminopathies, a group of heterogeneous disorders that arise due to mutations in the gene encoding lamin
A (LMNA). A significant increase in the frequency of nuclear envelope invaginations in the human Alzheimer’s
disease (AD) brain has recently been reported. Nuclear envelope invaginations are caused by pathogenic tau,
one of the two major pathological hallmarks of AD. Pathogenic tau-induced dysfunction of the lamin
nucleoskeleton drives nuclear envelope invagination and causes neuronal death, demonstrating that lamin
dysfunction has severe repercussions in the adult brain. These studies suggest that maintaining proper nuclear
architecture is important for survival and function of adult neurons. Our preliminary studies suggest that tau-
induced nuclear envelope invagination causes a toxic increase in RNA export, and that RNA quality control is
compromised in tauopathy. The proposed experiments test the overall hypothesis that tau-induced nuclear
envelope invaginations cause a toxic increase in RNA export that overwhelms RNA quality control machinery.
The overall goals of this proposal are to 1) Define the role of tau-induced nuclear envelope invaginations on
RNA export, 2) Identify the mechanism whereby genetic and pharmacologic reduction of RNA export suppress
tau-induced neurotoxicity, and 3) Determine if limited clearance of RNA transcripts by nonsense-mediated
RNA decay contributes to tau and age-induced neurotoxicity. We combine studies in Drosophila, induced
pluripotent stem cell (iPSC)-derived neurons from AD patients, and postmortem human AD brain tissue to
address causality, test hypotheses in brains of aged animals with functional neuronal networks, and determine
relevance to human AD. If our hypothesis is correct, a model will emerge that puts the lamin nucleoskeleton,
nuclear envelope, and RNA handling at the central interface between aging and tauopathy. We anticipate that
a multi-system investigation into the repercussions of nuclear envelope invagination will have a major impact
on disorders involving nuclear architecture disruption beyond AD, aging and related tauopathies, and could
lead to future development of novel, mechanism-based therapies.
项目摘要
核被膜是包裹基因组的脂质双层,
细胞质和核质。虽然细胞核通常被描绘成一个被光滑球体包围的球体,
在核膜的表面,光滑的外部可以被核膜的管状内陷中断
包裹在核内部深处。这种结构被称为“核质网”。增加
核膜内陷的频率发生在包括各种癌症,病毒感染,
和核纤层蛋白病,一组异质性疾病,由于核纤层蛋白编码基因的突变而引起
A(LMNA)。阿尔茨海默病患者核被膜内陷频率显著增加
脑疾病(AD)的研究最近有报道。核膜内陷由致病性tau蛋白引起,
AD的两个主要病理标志之一。致病性tau诱导的核纤层蛋白功能障碍
核骨架驱动核膜内陷并导致神经元死亡,表明核纤层蛋白
功能障碍对成年人的大脑有严重的影响。这些研究表明,保持适当的核
结构对于成年神经元的存活和功能是重要的。我们的初步研究表明tau-
诱导的核膜内陷导致RNA输出的毒性增加,并且RNA质量控制是
在tau蛋白病中受损。拟议的实验测试了总体假设,即tau诱导的核
包膜内陷导致RNA输出的毒性增加,其破坏了mRNA质量控制机制。
该提案的总体目标是:1)定义tau诱导的核膜内陷在
RNA输出,2)确定遗传和药理学减少RNA输出抑制
tau诱导的神经毒性,和3)确定是否通过无义介导的神经毒性限制RNA转录物的清除。
RNA衰变有助于tau蛋白和年龄诱导的神经毒性。我们联合收割机结合果蝇的研究,诱导
来自AD患者的多能干细胞(iPSC)衍生的神经元和死后人AD脑组织,
解决因果关系,在具有功能性神经元网络的老年动物大脑中测试假设,并确定
与人类AD的关系如果我们的假设是正确的,一个模型将会出现,
核被膜,以及衰老和tau蛋白病之间中央界面的RNA处理。我们预计
对核膜内陷影响的多系统研究将产生重大影响
涉及AD以外的核结构破坏、衰老和相关tau蛋白病的疾病,
导致未来开发新的、基于机制的疗法。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bess Frost其他文献
Bess Frost的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bess Frost', 18)}}的其他基金
Mechanisms of tau- and aging-induced neurological dysfunction: Focus on the nucleus
tau 蛋白和衰老引起的神经功能障碍的机制:聚焦于细胞核
- 批准号:
10343725 - 财政年份:2019
- 资助金额:
$ 58.37万 - 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
- 批准号:
9380979 - 财政年份:2015
- 资助金额:
$ 58.37万 - 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
- 批准号:
9189742 - 财政年份:2015
- 资助金额:
$ 58.37万 - 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
- 批准号:
9173275 - 财政年份:2015
- 资助金额:
$ 58.37万 - 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
- 批准号:
8904739 - 财政年份:2014
- 资助金额:
$ 58.37万 - 项目类别:
Mechanisms and Consequences of Heterochromatin Loss in Tauopathies
Tau蛋白病中异染色质丢失的机制和后果
- 批准号:
8760586 - 财政年份:2014
- 资助金额:
$ 58.37万 - 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
- 批准号:
8319393 - 财政年份:2010
- 资助金额:
$ 58.37万 - 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
- 批准号:
8061231 - 财政年份:2010
- 资助金额:
$ 58.37万 - 项目类别:
Tau-mediated chromatin regulation and neurodegeneration
Tau 介导的染色质调节和神经退行性变
- 批准号:
8197962 - 财政年份:2010
- 资助金额:
$ 58.37万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 58.37万 - 项目类别:
Research Grant














{{item.name}}会员




